146 related articles for article (PubMed ID: 11162701)
1. Technical report: lymph node enhancement at MRI with MnDPDP in primary hepatic carcinoma.
Burkill GJ; Mannion EM; Healy JC
Clin Radiol; 2001 Jan; 56(1):67-71. PubMed ID: 11162701
[TBL] [Abstract][Full Text] [Related]
2. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
Wang C
Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
[TBL] [Abstract][Full Text] [Related]
3. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
Grimm J; Müller-Hülsbeck S; Blume J; Biederer J; Heller M
Rofo; 2001 Mar; 173(3):266-72. PubMed ID: 11293872
[TBL] [Abstract][Full Text] [Related]
5. Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics.
Kim JH; Kim MJ; Park YN; Lee JT; Kim BR; Chung JB; Choi JS; Kim KS; Kim KW
Clin Radiol; 2008 Nov; 63(11):1195-204. PubMed ID: 18929037
[TBL] [Abstract][Full Text] [Related]
6. MnDPDP-enhanced MRI vs dual-phase spiral CT in the detection of hepatocellular carcinoma in cirrhosis.
Bartolozzi C; Donati F; Cioni D; Crocetti L; Lencioni R
Eur Radiol; 2000; 10(11):1697-702. PubMed ID: 11097390
[TBL] [Abstract][Full Text] [Related]
7. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
[TBL] [Abstract][Full Text] [Related]
8. MRI characteristics in focal hepatic disease before and after administration of MnDPDP: discriminant analysis as a diagnostic tool.
Helmberger TK; Laubenberger J; Rummeny E; Jung G; Sievers K; Döhring W; Meurer K; Reiser MF
Eur Radiol; 2002 Jan; 12(1):62-70. PubMed ID: 11868075
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
Padovani B; Lecesne R; Raffaelli C; Chevallier P; Drouillard J; Bruneton JN; Lambrechts M; Gordon P
Eur J Radiol; 1996 Nov; 23(3):205-11. PubMed ID: 9003926
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of hepatomas from nonhepatomatous masses: use of MnDPDP-enhanced MR images.
Liou J; Lee JK; Borrello JA; Brown JJ
Magn Reson Imaging; 1994; 12(1):71-9. PubMed ID: 8295510
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatic metastasis: manganese- and ferucarbotran-enhanced MR imaging.
Choi JY; Kim MJ; Kim JH; Kim SH; Ko HK; Lim JS; Oh YT; Chung JJ; Yoo HS; Lee JT; Kim KW
Eur J Radiol; 2006 Oct; 60(1):84-90. PubMed ID: 16920315
[TBL] [Abstract][Full Text] [Related]
12. Uptake of mangafodipir trisodium (MnDPDP) by hepatocellular carcinoma: correlation with unenhanced imaging findings and histopathologic features.
Chezmar JL; Redvanly RD; Sewell CW
Acad Radiol; 1996 Aug; 3 Suppl 2():S413-4. PubMed ID: 8796617
[No Abstract] [Full Text] [Related]
13. [Comparative study of four GRE sequences in MnDPDP-enhanced magnetic resonance imaging for primary hepatocellular carcinoma].
Guo T; Zhang XL; Chang RM; Zhang YZ
Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep; 23(9):946-8. PubMed ID: 13129729
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma.
Regge D; Campanella D; Anselmetti GC; Cirillo S; Gallo TM; Muratore A; Capussotti L; Galatola G; Floriani I; Aglietta M
Clin Radiol; 2006 Apr; 61(4):338-47. PubMed ID: 16546464
[TBL] [Abstract][Full Text] [Related]
15. Detection of neuroendocrine liver metastases with MnDPDP-enhanced MRI.
Rockall AG; Planche K; Power N; Nowosinska E; Monson JP; Grossman AB; Reznek RH
Neuroendocrinology; 2009; 89(3):288-95. PubMed ID: 19023191
[TBL] [Abstract][Full Text] [Related]
16. Mangafodipir trisodium-enhanced MRI for the detection and characterization of focal hepatic lesions: is delayed imaging useful?
Chung JJ; Kim MJ; Kim KW
J Magn Reson Imaging; 2006 May; 23(5):706-11. PubMed ID: 16565954
[TBL] [Abstract][Full Text] [Related]
17. Mangafodipir trisodium-enhanced magnetic resonance imaging for evaluation of pancreatic mass and mass-like lesions.
Eser G; Karabacakoglu A; Karakose S; Eser C; Kayacetin E
World J Gastroenterol; 2006 Mar; 12(10):1603-6. PubMed ID: 16570354
[TBL] [Abstract][Full Text] [Related]
18. Detection of colorectal liver metastases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-enhanced MRI, and spiral CT.
Bartolozzi C; Donati F; Cioni D; Procacci C; Morana G; Chiesa A; Grazioli L; Cittadini G; Cittadini G; Giovagnoni A; Gandini G; Maass J; Lencioni R
Eur Radiol; 2004 Jan; 14(1):14-20. PubMed ID: 14730384
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of rim and segmental MRI enhancement of colorectal hepatic metastasis after administration of mangafodipir trisodium.
Koh DM; Brown G; Meer Z; Norman AR; Husband JE
AJR Am J Roentgenol; 2007 Feb; 188(2):W154-61. PubMed ID: 17242222
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
Federle M; Chezmar J; Rubin DL; Weinreb J; Freeny P; Schmiedl UP; Brown JJ; Borrello JA; Lee JK; Semelka RC; Mattrey R; Dachman AH; Saini S; Harms SE; Mitchell DG; Anderson MW; Halford HH; Bennett WF; Young SW; Rifkin M; Gay SB; Ballerini R; Sherwin PF; Robison RO
J Magn Reson Imaging; 2000 Nov; 12(5):689-701. PubMed ID: 11050638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
